Rancés AC y cols. Abordaje mininvasivo de la acalasia en estadio final . Rev Argent Cir. 2025;117(1):1-6
5
Two paꢀents underwent minimally invasive reflux with an acceptable response to proton pump
esophagectomy, one with the laparoscopic transhiatal inhibitors and prokineꢀcs. The paꢀent with Roux-
a fistula that required
approach, and the other with the three-stage procedure en-Y bypass developed
in prone posiꢀon (Fig. 3). Five paꢀents underwent reintervenꢀons for flushing and drainage. Two paꢀents
hand-sewn cardioplasty, as described in Figure 4, and were lost to follow-up: one who underwent transhiatal
one paꢀent required resecꢀon of the esophagogastric esophagectomy and another who underwent
juncꢀon with Roux-en-Y reconstrucꢀon.
cardioplasty. In the remaining cases which conꢀnued
Postoperaꢀve complicaꢀons included one case to be monitored, there was significant relief of
of pneumonia in a paꢀent who underwent transhiatal dysphagia and adequate weight regain. The paꢀent
esophagectomy. Three paꢀents who underwent with megaesophagus and Chagas disease died due to
cardioplasty developed significant gastroesophageal cardiomyopathy.
■
FIGURE 3
Discussion
In the management of end-stage achalasia,
the strategy should focus on preserving the organ.
Recurrence of symptoms aꢂer surgical myotomy
should be managed with peroral endoscopic myotomy
(
POEM), redo Heller myotomy or on demand pneumaꢀc
1-4
dilaꢀons . Several procedures, such as cardioplasty,
are available before performing esophageal resecꢀon.
In our series, cardioplasty resulted a valid opꢀon to
ameliorate dysphagia but is quesꢀoned due to the
5
significant gastroesophageal reflux it may cause . In a
recent publicaꢀon, Ithurralde et al. describe resecꢀon
of the gastroesophageal juncꢀon and Roux-en-Y
reconstrucꢀon; this opꢀon could result in saꢀsfactory
outcomes and could be considered as an alternaꢀve
6
treatment prior to esophagectomy . Despite all these
conservaꢀve therapeuꢀc opꢀons, paꢀents should be
closely monitored for early detecꢀon of the need for
esophagectomy. Massivedilaꢀon oftheorgan(diameter
>
6 cm) is a predictor of esophagectomy. Therefore,
Surgical specimen of minimally invasive esophagectomy due to end-
stage achalasia
esophagectomy remains a potenꢀal indicaꢀon in
paꢀents with recurrent achalasia and radiologic
progression of the disease, especially in those who have
■
FIGURE 4
7,8
failed all minimally invasive treatments . Cardioplasty
was described many years ago and has evolved over
ꢀ
me to the point where there are currently several
publicaꢀons on laparoscopy, either using an endo
stapler or hand suture. The procedure consists of a
long esophageal myotomy in the full wall thickness. The
incision is extended 5 to 6 cm proximally and 1 to 2 cm
into the stomach to ensure complete dissecꢀon of the
lower esophageal sphincter and destrucꢀon of the high-
pressure zone. The length of the gastrostomy at the level
of the fundus must be proporꢀonal to the length of the
esophagotomy to prepare the anastomosis. Although
esophagogastrostomy allows adequate esophageal
emptying even in the presence of moꢀlity disorders, it
should be considered a rescue procedure and paꢀents
should receive proton pump inhibitors because of the
gastroesophageal reflux it causes9 . The management
of end-stage achalasia is complicated and represents
a significant therapeuꢀc challenge due to the limited
response to improve paꢀents’ symptoms and quality of
life.
,10
Cardioplasty